BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 8624985)

  • 1. Treating periodontal diseases with tetracycline-impregnated fibers: data and controversies.
    Greenstein G
    Compend Contin Educ Dent; 1995 May; 16(5):448-55; quiz 456. PubMed ID: 8624985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibiotic resistance profile of the subgingival microbiota following systemic or local tetracycline therapy.
    Rodrigues RM; Gonçalves C; Souto R; Feres-Filho EJ; Uzeda M; Colombo AP
    J Clin Periodontol; 2004 Jun; 31(6):420-7. PubMed ID: 15142209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Local antimicrobial therapies in periodontal disease.
    Kinane DF
    Ann R Australas Coll Dent Surg; 2000 Oct; 15():57-60. PubMed ID: 11709978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Debridement and local application of tetracycline-loaded fibres in the management of persistent periodontitis: results after 12 months.
    Aimetti M; Romano F; Torta I; Cirillo D; Caposio P; Romagnoli R
    J Clin Periodontol; 2004 Mar; 31(3):166-72. PubMed ID: 15016019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tetracycline fiber used alone or with scaling and root planing in periodontal maintenance patients: clinical results.
    Cattabriga M; Pedrazzoli V; Cattabriga A; Pannuti E; Trapani M; Verrocchi GC
    Quintessence Int; 1996 Jun; 27(6):395-400. PubMed ID: 8941833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of chronic periodontitis: a site-specific fiber placement technique.
    Anderson HH
    Pract Periodontics Aesthet Dent; 1996 Aug; 8(6):565-70; quiz 572. PubMed ID: 9242124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term effect of tetracycline fibers on recurrent lesions in periodontal maintenance patients.
    Corsair A
    Periodontal Clin Investig; 1994; 16(1):8-13. PubMed ID: 9055682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Principles and clinical applications of periodontal controlled drug delivery with tetracycline fibers.
    Tonetti MS; Pini-Prato G; Cortellini P
    Int J Periodontics Restorative Dent; 1994 Oct; 14(5):421-35. PubMed ID: 7751109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of adjunctive tetracycline fiber therapy with scaling and root planing: short-term clinical results.
    Yalcin F; Demirel K; Onan U
    Periodontal Clin Investig; 1999; 21(2):23-7. PubMed ID: 10860034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of bacterial resistance to tetracyclines in the treatment of periodontal diseases.
    Greenstein G
    J Periodontol; 1995 Nov; 66(11):925-32. PubMed ID: 8558393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of tetracycline fibres in the treatment of generalised aggressive periodontitis: clinical and microbiological findings.
    Sakellari D; Vouros I; Konstantinidis A
    J Int Acad Periodontol; 2003 Apr; 5(2):52-60. PubMed ID: 12760507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Local drug delivery in the treatment of periodontitis.
    Stanford TW
    Tex Dent J; 2001 Oct; 118(10):978-83. PubMed ID: 11764629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of the polymeric matrix as internal standard for quantitation of in vivo delivery of tetracycline HCl from Actisite tetracycline fiber during periodontal treatment.
    Litch JM; Encarnacion M; Chen S; Leonard J; Burkoth TL
    J Periodontal Res; 1996 Nov; 31(8):540-4. PubMed ID: 8971652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Controlled local delivery of tetracycline in the treatment of periodontitis.
    Killoy WJ; Cobb CM
    Compendium; 1992 Dec; 13(12):1150, 1152, 1154 passim. PubMed ID: 1298560
    [No Abstract]   [Full Text] [Related]  

  • 15. Tissue concentration and localization of tetracycline following site-specific tetracycline fiber therapy.
    Ciancio SG; Cobb CM; Leung M
    J Periodontol; 1992 Oct; 63(10):849-53. PubMed ID: 1403593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical responses following periodontal treatment by local drug delivery.
    Goodson JM; Hogan PE; Dunham SL
    J Periodontol; 1985 Nov; 56(11 Suppl):81-7. PubMed ID: 3866055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Actisite (tetracycline hydrochloride periodontal fiber): a critique.
    Baer PN
    Periodontal Clin Investig; 1994; 16(2):5-7. PubMed ID: 9055686
    [No Abstract]   [Full Text] [Related]  

  • 18. Monolithic tetracycline-containing fibers for controlled delivery to periodontal pockets.
    Goodson JM; Holborow D; Dunn RL; Hogan P; Dunham S
    J Periodontol; 1983 Oct; 54(10):575-9. PubMed ID: 6580409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Periodontal disease treatment by local drug delivery.
    Goodson JM; Offenbacher S; Farr DH; Hogan PE
    J Periodontol; 1985 May; 56(5):265-72. PubMed ID: 3891959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tetracycline and its analogues: a therapeutic paradigm in periodontal diseases.
    Weinberg MA; Bral M
    Crit Rev Oral Biol Med; 1998; 9(3):322-32. PubMed ID: 9715369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.